Back
Amicus Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
FOLD
Amicus Therapeutics, Inc.
Last Price:
$14.22
Seasonality Move:
4.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing slight selling pressure.
Amicus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.56 | Buy |
| 20-day SMA: | 10.54 | Buy |
| 50-day SMA: | 9.56 | Buy |
| 200-day SMA: | 7.7 | Buy |
| 8-day EMA: | 12.01 | Buy |
| 20-day EMA: | 10.88 | Buy |
| 50-day EMA: | 9.82 | Buy |
| 200-day EMA: | 8.59 | Buy |
Amicus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 91.17 | Buy |
| Chaikin Money Flow: | -8131640 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.13 - 11.57) | Buy |
| Bollinger Bands (100): | (7.33 - 9.95) | Buy |
Amicus Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics, Inc. Stock
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.21 while FOLD 8-day simple moving average is 11.56, which is a Buy signal.
-
The stock price of FOLD is 14.21 while Amicus Therapeutics, Inc. 20-day SMA is 10.54, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day simple moving average is 9.56 while FOLD share price is 14.21, making it a Buy technically.
-
FOLD stock price is 14.21 and Amicus Therapeutics, Inc. 200-day simple moving average is 7.70, creating a Buy signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
80
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. a Buy or a Sell?
-
Amicus Therapeutics, Inc. stock is rated a BuyThe current Amicus Therapeutics, Inc. [FOLD] share price is $14.21. The Score for FOLD is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics, Inc. Stock Info
Market Cap:
4.4B
Price in USD:
14.21
Share Volume:
32.5M
Amicus Therapeutics, Inc. 52-Week Range
52-Week High:
14.36
52-Week Low:
5.51
Buy
80
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Amicus Therapeutics, Inc. Share Price Forecast
-
What is the Amicus Therapeutics, Inc. stock price today?The Amicus Therapeutics, Inc. stock price is 14.21 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics, Inc. is not overvalued.
Is Amicus Therapeutics, Inc. Stock a Buy?
-
Amicus Therapeutics, Inc. share price is 14.21 while FOLD 8-day exponential moving average is 12.01, which is a Buy signal.
-
The stock price of FOLD is 14.21 while Amicus Therapeutics, Inc. 20-day EMA is 10.88, which makes it a Buy.
-
Amicus Therapeutics, Inc. 50-day exponential moving average is 9.82 while FOLD share price is 14.21, making it a Buy technically.
-
FOLD stock price is 14.21 and Amicus Therapeutics, Inc. 200-day simple moving average is 8.59, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics, Inc.
Is Amicus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.27 per share.
Technical Analysis of Amicus Therapeutics, Inc.
Should I short Amicus Therapeutics, Inc. stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is 0.9, suggesting Amicus Therapeutics, Inc. is a Buy
-
Amicus Therapeutics, Inc. Relative Strength Index (RSI) is 91.17, which suggest Amicus Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Amicus Therapeutics, Inc. is (9.13 - 11.57), which suggest Amicus Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Amicus Therapeutics, Inc. is (7.33 - 9.95), which suggest Amicus Therapeutics, Inc. is a Buy
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.